Xequte User Forums
Xequte User Forums
Profile | Join | Active Topics | Search | Forum FAQ
     
Forum Tips
» This forum is for users to discuss their software problems and suggestions for improvement.  Remember that only a tiny percentage of our users experience such problems (To be precise less than 0.7% have ever posted on this forum)
» Include your software version number (as displayed in the About Box)
» Check the FAQ before posting as most common questions have already been answered
» You don't need to also e-mail us separately as our support team will respond to all questions on this forum
 
 All Forums
 Xequte User Forums
 DVD PixPlay
 Anti Inflammatory Drugs Market Size, Revenue, Tren

Note: You must be registered in order to post a reply.
To register, click here. Registration is FREE!

Screensize:
UserName:
Password:
Format Mode:
Format: BoldItalicizedUnderlineStrikethrough Align LeftCenteredAlign Right Horizontal Rule Insert HyperlinkInsert EmailInsert Image Insert CodeInsert QuoteInsert List
   
Message:

* HTML is OFF
* Forum Code is ON
Smilies
Smile [:)] Big Smile [:D] Cool [8D] Blush [:I]
Tongue [:P] Evil [):] Wink [;)] Clown [:o)]
Black Eye [B)] Eight Ball [8] Frown [:(] Shy [8)]
Shocked [:0] Angry [:(!] Dead [xx(] Sleepy [|)]
Kisses [:X] Approve [^] Disapprove [V] Question [?]

  Attach a photo to your post
 
Check here to subscribe to this topic.
   

T O P I C    R E V I E W
vandanamanturgekar Posted - Sep 24 2024 : 21:47:13
The global anti-inflammatory drugs market size reached USD 111.42 Billion in 2021 and is expected to register a revenue CAGR of 9.3% during the forecast period, according to latest analysis by Emergen Research. Potential pipeline candidates is the main factor driving the market revenue growth. For instance, the monoclonal antibody mirikizumab (LY3074828) fulfilled the primary and all significant secondary objectives in the LUCENT-1 ulcerative colitis Phase 3 study, according to a March announcement from Lilly. The drug's potential as a therapy for moderate to severe ulcerative colitis was assessed throughout the 12-week multicenter induction phase. The humanized monoclonal antibody attaches to the interleukin-23 p19 subunit (IL-23p19). A cytokine that promotes inflammation is interleukin-23. In March, Lilly bragged that the Phase 3 trial LUCENT-1, which used an anti-IL-23p19 monoclonal antibody, was the only one to show a reduction in bowel urgency in patients with moderate to severe ulcerative colitis. Mirikizumab can be used to treat ulcerative colitis and crohn's disease, according to Lilly.

Additionally, the report also gives an insight into product portfolios, costs, sales, production capacities, and market players. Raw materials, demand analysis, product flow, and distribution channels have been studied and surveyed extensively in this research report. The key growth trends and opportunities are offered through a thorough investigation and examination of the market. A detailed course of development is offered in the report along with insights into businesses connected with it, which include firms, industries, organizations, vendors, and local manufacturers.

Download Free Exclusive Sample PDF @ https://www.emergenresearch.com/request-sample/1299

Key companies operating in the Anti Inflammatory Drugs market include:

AbbVie Inc., Johnson & Johnson Private Limited, Bristol-Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., Novartis AG, GSK plc, Lilly, Amgen Inc., Biogen

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Anti Inflammatory Drugs market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Key Benefits of the Report:

Comprehensive analysis of the competitive scenario and its changing dynamics
Analytical data with detailed SWOT analysis and Porter’s Five Forces analysis
In-depth 8-year analysis of the Global Anti Inflammatory Drugs Market
Critical understanding of the key market segments
Comprehensive analysis of the drivers, restraints, trends, and opportunities
Detailed regional analysis and extensive company profiling
Extensive assessment of current and emerging trends of the market
For more informative information, please visit us @ https://www.emergenresearch.com/industry-report/anti-inflammatory-drugs-market

Anti Inflammatory Drugs Market Segmentation:

Drug Class Outlook (Revenue, USD Billion; 2019-2030)
Anti-Inflammatory Biologics
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Corticosteroids
Route of Administration Outlook (Revenue, USD Billion; 2019-2030)
Oral
Injection
Inhalation
Topical
Application Outlook (Revenue, USD Billion; 2019-2030)
Autoimmune Inflammatory Diseases
Rheumatoid Arthritis
Psoriasis
Others
Respiratory Diseases
Others
 

Anti Inflammatory Drugs Market Segmentation by Regions:

North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Click here to Get customization @ https://www.emergenresearch.com/request-history/1299

Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.

More Related Reports By Emergen Research
IoT Platform Market
https://www.emergenresearch.com/industry-report/internet-of-things-platform-market

Cell to Pack Battery Market
https://www.emergenresearch.com/industry-report/cell-to-pack-battery-market

Medical Aesthetics Market
https://www.emergenresearch.com/industry-report/medical-aesthetics-market

Silanes Market
https://www.emergenresearch.com/industry-report/silanes-market

Healthy Snacks Market
https://www.emergenresearch.com/industry-report/healthy-snacks-market

Wastewater Recovery Systems Market
https://www.emergenresearch.com/industry-report/wastewater-recovery-systems-market

Air Freight Market
https://www.emergenresearch.com/industry-report/air-freight-market

Clear Whey Isolate Market
https://www.emergenresearch.com/industry-report/clear-whey-isolate-market

Particle Board Market
https://www.emergenresearch.com/industry-report/particle-board-market

AI in Telecommunication Market
https://www.emergenresearch.com/industry-report/artificial-intelligence-in-telecommunication-market


 

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services